These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 27120257
1. Rational Design of Potent and Selective Inhibitors of an Epoxide Hydrolase Virulence Factor from Pseudomonas aeruginosa. Kitamura S, Hvorecny KL, Niu J, Hammock BD, Madden DR, Morisseau C. J Med Chem; 2016 May 26; 59(10):4790-9. PubMed ID: 27120257 [Abstract] [Full Text] [Related]
2. Inhibiting an Epoxide Hydrolase Virulence Factor from Pseudomonas aeruginosa Protects CFTR. Bahl CD, Hvorecny KL, Bomberger JM, Stanton BA, Hammock BD, Morisseau C, Madden DR. Angew Chem Int Ed Engl; 2015 Aug 17; 54(34):9881-5. PubMed ID: 26136396 [Abstract] [Full Text] [Related]
6. Pseudomonas aeruginosa Cif defines a distinct class of α/β epoxide hydrolases utilizing a His/Tyr ring-opening pair. Bahl CD, Madden DR. Protein Pept Lett; 2012 Feb 14; 19(2):186-93. PubMed ID: 21933119 [Abstract] [Full Text] [Related]
7. Visualizing the Mechanism of Epoxide Hydrolysis by the Bacterial Virulence Enzyme Cif. Bahl CD, Hvorecny KL, Morisseau C, Gerber SA, Madden DR. Biochemistry; 2016 Feb 09; 55(5):788-97. PubMed ID: 26752215 [Abstract] [Full Text] [Related]
8. The Pseudomonas aeruginosa secreted protein PA2934 decreases apical membrane expression of the cystic fibrosis transmembrane conductance regulator. MacEachran DP, Ye S, Bomberger JM, Hogan DA, Swiatecka-Urban A, Stanton BA, O'Toole GA. Infect Immun; 2007 Aug 09; 75(8):3902-12. PubMed ID: 17502391 [Abstract] [Full Text] [Related]
9. Purification, crystallization and preliminary X-ray diffraction analysis of Cif, a virulence factor secreted by Pseudomonas aeruginosa. Bahl CD, MacEachran DP, O'Toole GA, Madden DR. Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Jan 01; 66(Pt 1):26-8. PubMed ID: 20057063 [Abstract] [Full Text] [Related]
10. An epoxide hydrolase secreted by Pseudomonas aeruginosa decreases mucociliary transport and hinders bacterial clearance from the lung. Hvorecny KL, Dolben E, Moreau-Marquis S, Hampton TH, Shabaneh TB, Flitter BA, Bahl CD, Bomberger JM, Levy BD, Stanton BA, Hogan DA, Madden DR. Am J Physiol Lung Cell Mol Physiol; 2018 Jan 01; 314(1):L150-L156. PubMed ID: 28982736 [Abstract] [Full Text] [Related]
16. Biochemical and structural characterization of two cif-like epoxide hydrolases from Burkholderia cenocepacia. Taher NM, Hvorecny KL, Burke CM, Gilman MSA, Heussler GE, Adolf-Bryfogle J, Bahl CD, O'Toole GA, Madden DR. Curr Res Struct Biol; 2021 Jan 01; 3():72-84. PubMed ID: 34235487 [Abstract] [Full Text] [Related]
17. Epoxide-mediated differential packaging of Cif and other virulence factors into outer membrane vesicles. Ballok AE, Filkins LM, Bomberger JM, Stanton BA, O'Toole GA. J Bacteriol; 2014 Oct 01; 196(20):3633-42. PubMed ID: 25112474 [Abstract] [Full Text] [Related]
18. Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors. Takai K, Chiyo N, Nakajima T, Nariai T, Ishikawa C, Nakatani S, Ikeno A, Yamamoto S, Sone T. Bioorg Med Chem Lett; 2015 Apr 15; 25(8):1705-1708. PubMed ID: 25800114 [Abstract] [Full Text] [Related]
19. Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase. Taylor SJ, Soleymanzadeh F, Eldrup AB, Farrow NA, Muegge I, Kukulka A, Kabcenell AK, De Lombaert S. Bioorg Med Chem Lett; 2009 Oct 15; 19(20):5864-8. PubMed ID: 19758802 [Abstract] [Full Text] [Related]